Marzia Khan

Feature Writer

M.Sc. in Nanotechnology and Regenerative Medicine, B.Sc. in Biomedical Sciences

Marzia Khan is a lover of scientific research and innovation. She immerses herself in literature and novel therapeutics which she does through her position on the Royal Free Ethical Review Board. Marzia has a MSc in Nanotechnology and Regenerative Medicine as well as a BSc in Biomedical Sciences. She is currently working in the NHS and is engaging in a scientific innovation program.

Articles from Marzia

Insight into the Human Proteoform Project

The Human Proteoform Project aims to characterize known proteoforms, including specific protein molecules, and identify and analyze novel proteoforms in human cells, tissues, and fluids.

11 Apr 2023

Omics Approaches to Biomarker Analysis

Omics approaches can be used to identify novel biomarkers to aid in furthering diagnostics and therapeutics.

30 Jan 2023

Importance of Drug Sensitivity Testing in Cancer

To understand how a patient’s cancer may respond to drug treatment, it is possible to carry out an in vitro drug sensitivity and resistance test (DSRT).

30 Jan 2023

Genome Editing Applications in Drug Discovery

Genome editing consists of a method that aids scientists in modifying or editing the DNA of many organisms, such as plants, bacteria, and animals.

30 Jan 2023

High-Content vs. High-Throughput Screening Technologies

High-content screening (HCS) and high-throughput screening (HTS) were introduced more than a decade ago and are both analytical techniques used to study biological systems in parallel for various applications such as cell biology and drug discovery.

27 Jan 2023

What Role Does Molecular Dynamics play in Drug Discovery?

Molecular dynamics (MD) comprises a technique for computer simulation of complex systems modeled at the atomic scale with this article investigating its use in drug discovery.

26 Jan 2023

How can Standardization Help to Accelerate Drug Discovery?

The use of standardization within the drug discovery process may be a good strategy to improve the speed of drug discovery, which may aid with decreasing the overall length of the drug development and approval process.

25 Jan 2023

What are Biologics?

Biologics are a type of drug or vaccine that is made from a living organism. These drugs can consist of a variety of substances such as proteins, sugars, DNA, or cells.

16 Dec 2022

What is Pharmacovigilance?

Pharmacovigilance is a relatively new discipline used to describe the science and activities within the pharmacology industry.

25 Nov 2022

What is High Throughput Screening?

High throughput screening (HTS) can be described as an automated process that is able to identify active compounds at an accelerated level.

25 Nov 2022

Marzia Khan

Articles from Marzia

Insight into the Human Proteoform Project

Omics Approaches to Biomarker Analysis

Importance of Drug Sensitivity Testing in Cancer

Genome Editing Applications in Drug Discovery

High-Content vs. High-Throughput Screening Technologies

What Role Does Molecular Dynamics play in Drug Discovery?

How can Standardization Help to Accelerate Drug Discovery?

What are Biologics?

What is Pharmacovigilance?

What is High Throughput Screening?

The Last Piece of Our Genome: Sequencing the Y Chromosome

Understanding the Importance of Entrepreneurship in the Life Sciences Community

Supporting Informed Decisions on Malaria Biocontrol Interventions

Latest in Genomics